Latest News and Press Releases

Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "Virology and Bacteriology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Infectious Diseases Collaboration and Licensing Deals 2019-2025" has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the...

Global Virus Network strengthens its presence across the Americas and advances global capacity to address viral threats.

Dublin, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The "Thymalfasin Drugs Market by Indication (Cancer, Hepatitis B, Hepatitis C), Route of Administration (Intramuscular Injection, Subcutaneous Injection),...

GVN's Rising Stars Awardees receive a seed research grant and are assigned accomplished mentors to advance training and education for pandemic preparedness

GVN launches three-day program in partnership with USF to engage Tampa high school students in virology, pandemic response, and public health careers

Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "Virology and Bacteriology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...

WARREN, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of the Company’s outstanding...

WARREN, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of the Company’s outstanding...

Tevogen.AI’s model drastically reduces target analysis and has the potential to generate billions in cost savings across the healthcare system by streamlining early-stage drug discovery, reducing wet...